Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| UroGen Pharma Ltd. | 1,485,168 | reported | 21 Oct 2022 | tx 24+144,540−104,540 |
| SENESCO TECHNOLOGIES INC | 20,000 | reported | 15 Jun 2022 | tx 23+6,628,525 |
| Keros Therapeutics, Inc. | 10,500 | reported | 04 Jun 2025 | tx 38+4,034,935−3,559,452 |
| Prevail Therapeutics Inc. | 0 | reported | 22 Jan 2021 | tx 3+17,000−1,593,881 |
| ARQULE INC | 0 | reported | 16 Jan 2020 | tx 41+10,772,732−10,764,121 |
| LB PHARMACEUTICALS INC | 0 | reported | 12 Sept 2025 | tx 4+1,434,130−10,000,000 |
| Kite Pharma, Inc. | 0 | reported | 03 Oct 2017 | tx 35+2,241,938−2,782,623 |
2 purchases reported after at least 12 months of silence — most recent on 12 Sept 2025.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Sept 2025 | CONVERSION | LB PHARMACEUTICALS INC | 411,681 | — | |
| 12 Sept 2025 | PURCHASE | LB PHARMACEUTICALS INC | 1,000,000 | 15.00 USD | first after silence |
| 12 Sept 2025 | CONVERSION | LB PHARMACEUTICALS INC | 10,000,000 | — | deriv |
| 10 Sept 2025 | GRANT_AWARD | LB PHARMACEUTICALS INC | 22,449 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 5,250 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,500 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | Keros Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 16 Jun 2022 | EXERCISE | UroGen Pharma Ltd. | 2,211 | 5.00 USD | |
| 16 Jun 2022 | EXERCISE | UroGen Pharma Ltd. | 2,211 | 0.00 USD | deriv |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 3,539 | 0.00 USD | |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,914 | 0.00 USD | |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,723 | 0.00 USD | |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,723 | 0.00 USD | deriv |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 1,914 | 0.00 USD | deriv |
| 29 Nov 2022 | EXERCISE | Keros Therapeutics, Inc. | 3,539 | 0.00 USD | deriv |
| 21 Oct 2022 | EXERCISE | UroGen Pharma Ltd. | 47,999 | 5.94 USD | |
| 21 Oct 2022 | EXERCISE | UroGen Pharma Ltd. | 15,276 | 0.00 USD | deriv |
| 21 Oct 2022 | EXERCISE | UroGen Pharma Ltd. | 32,723 | 0.00 USD | deriv |
| 06 Jun 2022 | EXERCISE | UroGen Pharma Ltd. | 1,030 | 5.00 USD | |
| 06 Jun 2022 | EXERCISE | UroGen Pharma Ltd. | 1,030 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | SENESCO TECHNOLOGIES INC | 20,000 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | UroGen Pharma Ltd. | 6,817 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | UroGen Pharma Ltd. | 3,183 | 0.00 USD | deriv |
| 01 Jun 2022 | GRANT_AWARD | Keros Therapeutics, Inc. | 8,293 | 0.00 USD | deriv |